Stay updated on Pembrolizumab in Untreated Extensive SCLC Clinical Trial

Sign up to get notified when there's something new on the Pembrolizumab in Untreated Extensive SCLC Clinical Trial page.
Latest website image capture
Clouds background image

Latest updates to the Pembrolizumab in Untreated Extensive SCLC Clinical Trial page

  1. Check
    yesterday
    Change Detected
    Summary
    The revision tag on the page was updated from v3.5.3 to v3.5.4. This reflects a new version of the page in the content management system.
    Difference
    0.0%
    Check dated 2026-05-14T23:23:43.000Z thumbnail image
  2. Check
    8 days ago
    No Change Detected
  3. Check
    15 days ago
    Change Detected
    Summary
    A revision tag on the page was updated from v3.5.2 to v3.5.3, indicating a system update; study content and displayed information remain unchanged.
    Difference
    0.0%
    Check dated 2026-04-30T18:07:01.000Z thumbnail image
  4. Check
    22 days ago
    No Change Detected
  5. Check
    29 days ago
    Change Detected
    Summary
    Added Revision: v3.5.2 and removed Revision: v3.5.0.
    Difference
    0.0%
    Check dated 2026-04-16T11:53:40.000Z thumbnail image
  6. Check
    43 days ago
    Change Detected
    Summary
    Added the keyword 'Small cell lung carcinoma' and a new 'resources' section linking to the Genetic and Rare Diseases Information Center.
    Difference
    0.1%
    Check dated 2026-04-02T06:17:08.000Z thumbnail image
  7. Check
    58 days ago
    Change Detected
    Summary
    Revision history updated to include v3.5.0 and remove v3.4.3. This is a minor metadata update that does not affect study content or results.
    Difference
    0.0%
    Check dated 2026-03-18T20:29:27.000Z thumbnail image
  8. Check
    65 days ago
    Change Detected
    Summary
    Revision: v3.4.3 added in the page header, replacing Revision: v3.4.2.
    Difference
    0.0%
    Check dated 2026-03-11T18:49:04.000Z thumbnail image

Stay in the know with updates to Pembrolizumab in Untreated Extensive SCLC Clinical Trial

Enter your email address, and we'll notify you when there's something new on the Pembrolizumab in Untreated Extensive SCLC Clinical Trial page.